Costagliola D - Search Results

1

Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.

Gault N, Esposito-Farèse M, Revest M, Inamo J, Cabié A, Polard É, Hulot JS, Ghosn J, Chirouze C, Deconinck L, Diehl JL, Poissy J, Epaulard O, Lefèvre B, Piroth L, De Montmollin E, Oziol E, Etienne M, Laouénan C, Rossignol P, Costagliola D, Vidal-Petiot E; French-Covid cohort investigators, study group. Gault N, et al. Among authors: costagliola d. Fundam Clin Pharmacol. 2021 Dec;35(6):1141-1158. doi: 10.1111/fcp.12683. Epub 2021 May 16. Fundam Clin Pharmacol. 2021. PMID: 33876439 Free PMC article.

2

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L. Grabar S, et al. Among authors: costagliola d. Ann Intern Med. 2000 Sep 19;133(6):401-10. doi: 10.7326/0003-4819-133-6-200009190-00007. Ann Intern Med. 2000. PMID: 10975957

3

Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis.

Abgrall S, Matheron S, Le Moing V, Dupont C, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV. Abgrall S, et al. Among authors: costagliola d. J Acquir Immune Defic Syndr. 2001 Feb 1;26(2):151-8. doi: 10.1097/00042560-200102010-00007. J Acquir Immune Defic Syndr. 2001. PMID: 11242182

4

Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.

Abgrall S, Duval X, Joly V, Descamps D, Matheron S, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV. Abgrall S, et al. Among authors: costagliola d. Clin Infect Dis. 2003 Dec 1;37(11):1517-26. doi: 10.1086/379070. Epub 2003 Oct 29. Clin Infect Dis. 2003. PMID: 14614675

5

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P. Bonnet F, et al. Among authors: costagliola d. Cancer. 2004 Jul 15;101(2):317-24. doi: 10.1002/cncr.20354. Cancer. 2004. PMID: 15241829 Free article.

6

Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection.

Grabar S, Le Moing V, Goujard C, Egger M, Leport C, Kazatchkine MD, Weiss L, Costagliola D. Grabar S, et al. Among authors: costagliola d. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):284-92. doi: 10.1097/01.qai.0000160925.33935.72. J Acquir Immune Defic Syndr. 2005. PMID: 15980687

7

Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.

Abgrall S, Yeni PG, Bouchaud O, Costagliola D; Clinical Epidemiology Group from the French Hospital Database on HIV. Abgrall S, et al. Among authors: costagliola d. AIDS. 2006 Oct 24;20(16):2099-106. doi: 10.1097/01.aids.0000247581.93201.79. AIDS. 2006. PMID: 17053356

8

Yearly number of patients diagnosed with primary HIV-1 infection in France estimated by a capture-recapture approach.

Lievre L, Deveau C, Gerbe J, Enel P, Tran L, De Castro N, Costagliola D, Meyer L; Primo Study Group; Clinical Epidemieology Group. Lievre L, et al. Among authors: costagliola d. AIDS. 2006 Nov 28;20(18):2392-5. doi: 10.1097/QAD.0b013e32801104b0. AIDS. 2006. PMID: 17117029

9

Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).

Launay O, Duval X, Dalban C, Descamps D, Peytavin G, Certain A, Mouajjah S, Ralaimazava P, Verdon R, Costagliola D, Clavel F; ANRS 109 VISTA Study Group. Launay O, et al. Among authors: costagliola d. Antivir Ther. 2006;11(7):889-99. Antivir Ther. 2006. PMID: 17302251 Clinical Trial.

10

Frequency, determinants and consequences of delayed access to care for HIV infection in France.

Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C, Costagliola D; ANRS C004 French Hospital Database on HIV Clinical Epidemiological Group. Lanoy E, et al. Among authors: costagliola d. Antivir Ther. 2007;12(1):89-96. doi: 10.1177/135965350701200111. Antivir Ther. 2007. PMID: 17503752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

727 results

Search Page